Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Am J Geriatr Psychiatry ; 32(7): 808-820, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38320908

ABSTRACT

OBJECTIVE: To determine associations between Vitamin D (VD) levels and clinical depression through the Geriatric Depression Scale (GDS) and its questions and subdomains, stratified by demographics and Hispanic/Latino ethnicity (HLE). DESIGN, SETTING, AND PARTICIPANTS: A cohort of 299 Project FRONTIER participants aged 62.6 ± 11.7 years old, 70.9% female, and 40.5% HLE were used. Standard correlation and regression analyses were employed. MEASUREMENTS: The main outcome measures were VD (serum 25(OH)-VD) level, GDS-30 (30-item questionnaire), GDS-30 subfactors and questions, and HLE status. VD categories were defined as VD deficiency (VDD; ≤20 ng/mL), VD insufficiency (VDI; 21-29 ng/mL), VD sufficiency (30-38 ng/mL) and high VD sufficiency (>38 ng/mL). RESULTS: The majority (61.5%) of samples fell into VDD/VDI categories. A significant negative association was found between VD level and GDS-30 total score. VD level was negatively correlated with Dysphoria and Meaninglessness GDS-30 subfactors. Although GDS subfactors were similar between HLE and non-HLE groups, VD levels were significantly lower in HLE samples. Finally, HLE/non-HLE groups were differentially stratified across VD categories. Only 4% of HLEs fell into the high VD sufficient category, suggesting low VD supplementation. CONCLUSION: A significant negative association between VD level and depressive symptoms was revealed in our aging Project FRONTIER participants. HLE individuals were overrepresented in VDD/VDI samples, and VDD/VDI was associated primarily with the Dysphoria GDS subdomain. Regression analysis predicted high VD sufficiency (95.5 ng/mL) to be associated with no depressive symptoms (GDS=0). Our results underscore troubling disparities in VD-related depressive symptoms between HLE and non-HLE populations.


Subject(s)
Depression , Health Status Disparities , Vitamin D Deficiency , Humans , Female , Vitamin D Deficiency/epidemiology , Vitamin D Deficiency/blood , Male , Middle Aged , Depression/epidemiology , Depression/blood , Aged , Texas/epidemiology , Hispanic or Latino/statistics & numerical data , Rural Population/statistics & numerical data , Vitamin D/blood
2.
Biochim Biophys Acta Mol Basis Dis ; 1863(5): 1026-1036, 2017 May.
Article in English | MEDLINE | ID: mdl-28130199

ABSTRACT

The purpose of this review article is to understand the current literature on obesity, diabetes and therapeutic avenues across the world. Diabetes is a chronic lifestyle condition that affects millions of people worldwide and it is a major health concern in our society. Diabetes and obesity are associated with various conditions, including non-modifiable and modifiable risk factors. Early detectable markers are not well established to detect pre-diabetes and as a result, it becomes diabetes. Several published epidemiological studies were assessed and the findings were summarized. Resources from published studies were used to identify criteria used for pre-diabetes, the role of diet in pre-diabetics and potential risks and characteristics associated with pre-diabetes. Preventive strategies are needed to combat diabetes. Individuals diagnosed with pre-diabetes need detailed education, need to fully understand the risk factors and have the ability to manage diabetes. Interventions exist that include chronic disease self-management programs, lifestyle interventions and pharmacological strategies. Obesity plays a large role in causing pre-diabetes and diabetes. Critical analysis of existing epidemiological research data suggests that additional research is needed to determine the efficacy of interventions. This article is part of a Special Issue entitled: Oxidative Stress and Mitochondrial Quality in Diabetes/Obesity and Critical Illness Spectrum of Diseases - edited by P. Hemachandra Reddy.


Subject(s)
Diabetes Mellitus/epidemiology , Obesity/complications , Animals , Diabetes Mellitus/diagnosis , Diabetes Mellitus/genetics , Diabetes Mellitus/therapy , Diet Therapy , Exercise Therapy , Humans , Insulin/genetics , Life Style , Obesity/therapy , Risk Factors
3.
J Alzheimers Dis Rep ; 7(1): 557-574, 2023.
Article in English | MEDLINE | ID: mdl-37313490

ABSTRACT

Alzheimer's disease (AD) and Alzheimer's disease-related disorders (ADRD) are late-onset, age-related progressive neurodegenerative disorders, characterized by memory loss and multiple cognitive impairments. Current research indicates that Hispanic Americans are at an increased risk for AD/ADRD and other chronic conditions such as diabetes, obesity, hypertension, and kidney disease, and given their rapid growth in numbers, this may contribute to a greater incidence of these disorders. This is particularly true for the state of Texas, where Hispanics are the largest group of ethnic minorities. Currently, AD/ADRD patients are taken care by family caregivers, which puts a tremendous burden on family caregivers who are usually older themselves. The management of disease and providing necessary/timely support for patients with AD/ADRD is a challenging task. Family caregivers support these individuals in completing basic physical needs, maintaining a safe living environment, and providing necessary planning for healthcare needs and end-of-life decisions for the remainder of the patient's lifetime. Family caregivers are mostly over 50 years of age and provide all-day care for individuals with AD/ADRD, while also managing their health. This takes a significant toll on the caregiver's own physiological, mental, behavioral, and social health, in addition to low economic status. The purpose of our article is to assess the status of Hispanic caregivers. We also focused on effective interventions for family caregivers of persons with AD/ADRD involving both educational and psychotherapeutic components, and a group format further enhances effectiveness. Our article discusses innovative methods and validations to support Hispanic family caregivers in rural West Texas.

4.
J Alzheimers Dis ; 72(s1): S11-S35, 2019.
Article in English | MEDLINE | ID: mdl-31104030

ABSTRACT

The purpose of the 'First Regional Healthy Aging and Dementia Research Symposium' was to discuss the latest research in healthy aging and dementia research, public health trends related to neurodegenerative diseases of aging, and community-based programs and research studying health, nutrition, and cognition. This symposium was organized by the Garrison Institute on Aging (GIA) of the Texas Tech University Health Sciences Center (TTUHSC), and was held in Lubbock, Texas, October 24-25, 2018. The Symposium joined experts from educational and research institutions across the United States. The two-day Symposium included all GIA staff and researchers. Students, postdoctoral fellows, and faculty members involved in dementia research presented at the Symposium. Healthcare professionals, from geriatricians to social workers working with patients with neurodegenerative diseases, also presented. In addition, experts traveled from across the United States to participate. This event was comprised of multiple sessions, each with several oral presentations, followed by questions and answers, and discussion.


Subject(s)
Biomedical Research/trends , Congresses as Topic/trends , Dementia/epidemiology , Dementia/psychology , Healthy Aging/physiology , Healthy Aging/psychology , Biomedical Research/methods , Humans , Texas/epidemiology
5.
J Alzheimers Dis ; 61(3): 843-866, 2018.
Article in English | MEDLINE | ID: mdl-29332042

ABSTRACT

The purpose of our article is to assess the current understanding of Indian spice, curcumin, against amyloid-ß (Aß)-induced toxicity in Alzheimer's disease (AD) pathogenesis. Natural products, such as ginger, curcumin, and gingko biloba have been used as diets and dietary supplements to treat human diseases, including cancer, cardiovascular, respiratory, infectious, diabetes, obesity, metabolic syndromes, and neurological disorders. Products derived from plants are known to have protective effects, including anti-inflammatory, antioxidant, anti-arthritis, pro-healing, and boosting memory cognitive functions. In the last decade, several groups have designed and synthesized curcumin and its derivatives and extensively tested using cell and mouse models of AD. Recent research on Aß and curcumin has revealed that curcumin prevents Aß aggregation and crosses the blood-brain barrier, reach brain cells, and protect neurons from various toxic insults of aging and Aß in humans. Recent research has also reported that curcumin ameliorates cognitive decline and improves synaptic functions in mouse models of AD. Further, recent groups have initiated studies on elderly individuals and patients with AD and the outcome of these studies is currently being assessed. This article highlights the beneficial effects of curcumin on AD. This article also critically assesses the current limitations of curcumin's bioavailability and urgent need for new formulations to increase its brain levels to treat patients with AD.


Subject(s)
Alzheimer Disease/drug therapy , Blood-Brain Barrier/drug effects , Curcumin/pharmacology , Neuroprotective Agents/pharmacology , Alzheimer Disease/pathology , Amyloid beta-Peptides/toxicity , Animals , Blood-Brain Barrier/metabolism , Disease Models, Animal , Humans , Mice , Randomized Controlled Trials as Topic , Spices
6.
Front Aging Neurosci ; 8: 85, 2016.
Article in English | MEDLINE | ID: mdl-27242507

ABSTRACT

The objective of our study was to evaluate the exercise and educational intervention in the city of Lubbock via GET FiT Lubbock (GFL) program. The GFL program was designed to increase exercise and educational opportunities, which positively impact health risk factors in Lubbock residents. The GFL program design included the recruitment of subjects to participate on a team that consisted of four individuals, each subject tracked their exercise minutes, and their educational session attendance. The tracking of exercise and educational sessions was done on the GFL website. Biometric testing was conducted pre- and post- intervention. The program was located within the Lubbock community in places that were close to their place of residence. The intervention included walking and educational sessions, including goal setting lectures, nutrition information, and exercise demonstrations. Study participants, included male and female adults who tracked their exercise time and educational sessions. Exercise minutes and educational session attendance were self-reported. Our data analysis revealed that significant difference was found between pre- and post- intervention measures, including weight, body mass index (BMI), high-density lipoprotein (HDL). Significant difference was found for weight, BMI, and HDL in females. Based on these findings, we conclude that the intervention showed positive effects on exercise and lifestyle.

7.
Front Aging Neurosci ; 7: 215, 2015.
Article in English | MEDLINE | ID: mdl-26696877

ABSTRACT

The Texas Tech University Health Sciences (TTUHSC) Garrison Institute on Aging (GIA) was established to promote healthy aging through cutting edge research on Alzheimer's disease (AD) and other diseases of aging, through innovative educational and community outreach opportunities for students, clinicians, researchers, health care providers, and the public. The GIA sponsors the Lubbock Retired and Senior Volunteer Program (RSVP). According to RSVP Operations Handbook, RSVP is one of the largest volunteer efforts in the nation. Through this program, volunteer skills and talents can be matched to assist with community needs. It is a federally funded program under the guidance of the Corporation for National and Community Service (CNCS) and Senior Corps (SC). Volunteers that participate in RSVP provide service in the following areas: food security, environmental awareness building and education, community need-based volunteer programs, and veteran services.

8.
J Alzheimers Dis ; 48(2): 547-55, 2015.
Article in English | MEDLINE | ID: mdl-26402018

ABSTRACT

The Garrison Institute on Aging (GIA) is an established institute within Texas Tech University Health Sciences Center, whose mission is to promote healthy aging through cutting-edge research on Alzheimer's disease (AD) and other diseases of aging through innovative educational opportunities for students, clinicians, researchers, health care professionals, and the public. The GIA has multiple programs, including both research and education on healthy aging and AD, community outreach, caregiving, the Retired Senior Volunteer Program, Healthy Lubbock, the GIA Brain Bank, healthy aging seminars, research seminars, and collaborations and scholarships. The GIA programs connect basic and clinical researchers and health care professionals, and provide a unique environment to help our growing elderly population and patients with AD and their families.


Subject(s)
Academic Medical Centers , Alzheimer Disease/therapy , Health Services for the Aged , Alzheimer Disease/genetics , Alzheimer Disease/metabolism , Animals , Brain , Community-Institutional Relations , Geriatrics/education , Geriatrics/methods , Humans , Multiple Sclerosis/metabolism , Multiple Sclerosis/therapy , Patient Education as Topic , Texas , Tissue Banks , Volunteers
SELECTION OF CITATIONS
SEARCH DETAIL